125 related articles for article (PubMed ID: 8902098)
41. Pathogenesis of 2,2'-dichlorodiethyl sulfide in hairless guinea pigs.
Yourick JJ; Dawson JS; Benton CD; Craig ME; Mitcheltree LW
Toxicology; 1993 Nov; 84(1-3):185-97. PubMed ID: 8266337
[TBL] [Abstract][Full Text] [Related]
42. Model for assessing efficacy of topical skin protectants against sulfur mustard vapor using hairless guinea pigs.
Snider TH; Matthews MC; Braue EH
J Appl Toxicol; 1999 Dec; 19 Suppl 1():S55-8. PubMed ID: 10594902
[TBL] [Abstract][Full Text] [Related]
43. Comparative morphology of sulfur mustard effects in the hairless guinea pig and a human skin equivalent.
Petrali JP; Oglesby SB; Hamilton TA; Mills KR
J Submicrosc Cytol Pathol; 1993 Jan; 25(1):113-8. PubMed ID: 8462065
[TBL] [Abstract][Full Text] [Related]
44. Protective effect of topical iodine containing anti-inflammatory drugs against sulfur mustard-induced skin lesions.
Wormser U; Sintov A; Brodsky B; Casillas RP; Nyska A
Arch Toxicol; 2004 Mar; 78(3):156-66. PubMed ID: 14618300
[TBL] [Abstract][Full Text] [Related]
45. Intramuscular prednisolone pretreatment does not influence the dermal lesions induced by topical sulfur mustard.
Ballantyne B
Vet Hum Toxicol; 1986 Jun; 28(3):204-6. PubMed ID: 3727348
[TBL] [Abstract][Full Text] [Related]
46. Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice.
Wormser U; Langenbach R; Peddada S; Sintov A; Brodsky B; Nyska A
Toxicol Appl Pharmacol; 2004 Oct; 200(1):40-7. PubMed ID: 15451306
[TBL] [Abstract][Full Text] [Related]
47. Acute ocular effects of mustard gas: ultrastructural pathology and immunohistopathology of exposed rabbit cornea.
Petrali JP; Dick EJ; Brozetti JJ; Hamilton TA; Finger AV
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S173-5. PubMed ID: 11428631
[TBL] [Abstract][Full Text] [Related]
48. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM).
Babin MC; Ricketts K; Skvorak JP; Gazaway M; Mitcheltree LW; Casillas RP
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S141-4. PubMed ID: 11428627
[TBL] [Abstract][Full Text] [Related]
49. Effects of selected arginine analogues on sulphur mustard toxicity in human and hairless guinea pig skin keratinocytes.
Sawyer TW; Risk D
Toxicol Appl Pharmacol; 2000 Feb; 163(1):75-85. PubMed ID: 10662607
[TBL] [Abstract][Full Text] [Related]
50. Use of methyl salicylate as a simulant to predict the percutaneous absorption of sulfur mustard.
Riviere JE; Smith CE; Budsaba K; Brooks JD; Olajos EJ; Salem H; Monteiro-Riviere NA
J Appl Toxicol; 2001; 21(2):91-9. PubMed ID: 11288131
[TBL] [Abstract][Full Text] [Related]
51. Skin hydration and transepidermal water loss in patients with a history of sulfur mustard contact: a case-control study.
Davoudi SM; Keshavarz S; Sadr B; Shohrati M; Naghizadeh MM; Farsinejad K; Rashighi-Firouzabadi M; Zartab H; Firooz A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):940-4. PubMed ID: 19453792
[TBL] [Abstract][Full Text] [Related]
52. Time course of skin features and inflammatory biomarkers after liquid sulfur mustard exposure in SKH-1 hairless mice.
Mouret S; Wartelle J; Batal M; Emorine S; Bertoni M; Poyot T; Cléry-Barraud C; Bakdouri NE; Peinnequin A; Douki T; Boudry I
Toxicol Lett; 2015 Jan; 232(1):68-78. PubMed ID: 25275893
[TBL] [Abstract][Full Text] [Related]
53. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas.
Momeni AZ; Enshaeih S; Meghdadi M; Amindjavaheri M
Arch Dermatol; 1992 Jun; 128(6):775-80. PubMed ID: 1599263
[TBL] [Abstract][Full Text] [Related]
54. The time-dependent effect of 2,2'-dichlorodiethyl sulfide (sulfur mustard, HD, 1,1'-thiobis [2-chloroethane]) on the lymphocyte viability and the kinetics of protection by poly(ADP-ribose) polymerase inhibitors.
Meier HL
Cell Biol Toxicol; 1996 Jun; 12(3):147-53. PubMed ID: 8817060
[TBL] [Abstract][Full Text] [Related]
55. Toxicokinetics of topical sulfur mustard penetration, disposition, and vascular toxicity in isolated perfused porcine skin.
Riviere JE; Brooks JD; Williams PL; Monteiro-Riviere NA
Toxicol Appl Pharmacol; 1995 Nov; 135(1):25-34. PubMed ID: 7482537
[TBL] [Abstract][Full Text] [Related]
56. Acute and long-term transcriptional responses in sulfur mustard-exposed SKH-1 hairless mouse skin.
Vallet V; Poyot T; Cléry-Barraud C; Coulon D; Sentenac C; Peinnequin A; Boudry I
Cutan Ocul Toxicol; 2012 Mar; 31(1):38-47. PubMed ID: 21939433
[TBL] [Abstract][Full Text] [Related]
57. Pathogenesis and treatment of skin lesions caused by sulfur mustard.
Poursaleh Z; Ghanei M; Babamahmoodi F; Izadi M; Harandi AA; Emadi SE; Taghavi NO; Sayad-Nouri SS; Emadi SN
Cutan Ocul Toxicol; 2012 Sep; 31(3):241-9. PubMed ID: 22122127
[TBL] [Abstract][Full Text] [Related]
58. Sulfur mustard-induced skin burns in weanling swine evaluated clinically and histopathologically.
Reid FM; Graham J; Niemuth NA; Singer AW; Janny SJ; Johnson JB
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S153-60. PubMed ID: 11428629
[TBL] [Abstract][Full Text] [Related]
59. Sulfur mustard cutaneous injury characterization based on SKH-1 mouse model: relevance of non-invasive methods in terms of wound healing process analyses.
Cléry-Barraud C; Nguon N; Vallet V; Sentenac C; Four E; Arlaud C; Coulon D; Boudry I
Skin Res Technol; 2013 Feb; 19(1):e146-56. PubMed ID: 22741598
[TBL] [Abstract][Full Text] [Related]
60. Pathogenesis of skin lesions caused by sulfur mustard.
Vogt RF; Dannenberg AM; Schofield BH; Hynes NA; Papirmeister B
Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S71-83. PubMed ID: 6233199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
